Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …

Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life
threatening, especially in elderly people and in patients who have dysbiosis of the gut …

Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …

AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …

Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid-
related disorders and use has significantly increased over the last few decades. PPIs are …

Proton pump inhibitors are among the most commonly prescribed classes of drugs, and their
use is increasing, in particular for long‐term treatment, often being over‐prescribed and …

Background Recognition of a broad spectrum of disease and development of Clostridium
difficile infection (CDI) and recurrent CDI (rCDI) in populations previously considered to be …

BackgroundClostridium difficile infection (CDI) has been extensively described in healthcare
settings; however, risk factors associated with community-acquired (CA) CDI remain …

Background & Aims The effects of transoral incisionless fundoplication (TIF) and
laparoscopic Nissen fundoplication (LNF) have been compared with those of proton pump …